Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
44.71
-0.27 (-0.60%)
Feb 12, 2026, 4:00 PM EST - Market closed
KNSA Stock Forecast
Stock Price Forecast
The 6 analysts that cover KNSA stock have a consensus rating of "Strong Buy" and an average price target of $52.33, which forecasts a 17.04% increase in the stock price over the next year. The lowest target is $45 and the highest is $60.
Price Target: $52.33 (+17.04%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 13, 2026.
Analyst Ratings
The average analyst rating for KNSA stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 4 | 4 | 4 | 4 |
| Buy | 4 | 4 | 4 | 4 | 4 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 8 | 8 | 8 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $48 → $50 | Buy | Maintains | $48 → $50 | +11.83% | Jan 13, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $45 → $55 | Strong Buy | Maintains | $45 → $55 | +23.01% | Oct 29, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $45 → $50 | Strong Buy | Maintains | $45 → $50 | +11.83% | Oct 17, 2025 |
| Wedbush | Wedbush | Buy Maintains $38 → $44 | Buy | Maintains | $38 → $44 | -1.59% | Oct 13, 2025 |
| TD Cowen | TD Cowen | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +34.20% | Sep 29, 2025 |
Financial Forecast
Revenue This Year
689.83M
from 423.24M
Increased by 62.99%
Revenue Next Year
919.51M
from 689.83M
Increased by 33.30%
EPS This Year
0.94
from -0.60
EPS Next Year
1.60
from 0.94
Increased by 69.07%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 711.4M | 971.1M | ||||
| Avg | 689.8M | 919.5M | ||||
| Low | 660.5M | 819.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 68.1% | 40.8% | ||||
| Avg | 63.0% | 33.3% | ||||
| Low | 56.1% | 18.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.22 | 2.55 | ||||
| Avg | 0.94 | 1.60 | ||||
| Low | 0.74 | 1.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 170.1% | ||||
| Avg | - | 69.1% | ||||
| Low | - | 14.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.